B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.
(33/88)
(+info)
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
(34/88)
(+info)
The role of costimulatory molecules in allergic disease and asthma.
(35/88)
(+info)
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
(36/88)
(+info)
Clinical importance of B7-H3 expression in human pancreatic cancer.
(37/88)
(+info)
Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.
(38/88)
(+info)
Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
(39/88)
(+info)
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
(40/88)
(+info)